Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002335034 | SCV002639902 | uncertain significance | Cardiovascular phenotype | 2019-09-12 | criteria provided, single submitter | clinical testing | The p.L15479F variant (also known as c.46435C>T), located in coding exon 153 of the TTN gene, results from a C to T substitution at nucleotide position 46435. The leucine at codon 15479 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV003481279 | SCV004225816 | uncertain significance | not provided | 2022-06-13 | criteria provided, single submitter | clinical testing |